Quantinno Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.9M | Buy |
392,691
+86,440
| +28% | +$16M | 0.31% | 33 |
|
|
2025
Q1 | $64.2M | Buy |
306,251
+116,820
| +62% | +$24.5M | 0.42% | 28 |
|
|
2024
Q4 | $33.7M | Buy |
189,431
+31,871
| +20% | +$5.66M | 0.33% | 36 |
|
|
2024
Q3 | $31.1M | Buy |
157,560
+54,769
| +53% | +$10.8M | 0.4% | 31 |
|
|
2024
Q2 | $17.6M | Buy |
102,791
+767
| +0.8% | +$132K | 0.32% | 41 |
|
|
2024
Q1 | $18.6M | Buy |
102,024
+35,789
| +54% | +$6.52M | 0.4% | 35 |
|
|
2023
Q4 | $10.3M | Buy |
66,235
+5,305
| +9% | +$822K | 0.36% | 34 |
|
|
2023
Q3 | $9.08M | Buy |
60,930
+21,692
| +55% | +$3.23M | 0.41% | 30 |
|
|
2023
Q2 | $5.29M | Sell |
39,238
-5,894
| -13% | -$794K | 0.3% | 48 |
|
|
2023
Q1 | $7.19M | Buy |
45,132
+3,491
| +8% | +$556K | 0.48% | 24 |
|
|
2022
Q4 | $6.73M | Buy |
41,641
+15,636
| +60% | +$2.53M | 0.5% | 26 |
|
|
2022
Q3 | $3.49M | Buy |
26,005
+4,375
| +20% | +$587K | 0.45% | 28 |
|
|
2022
Q2 | $3.31M | Buy |
21,630
+4,369
| +25% | +$669K | 0.48% | 26 |
|
|
2022
Q1 | $2.8M | Buy |
17,261
+3,958
| +30% | +$642K | 0.43% | 34 |
|
|
2021
Q4 | $1.8M | Buy |
+13,303
| New | +$1.8M | 0.33% | 63 |
|
|
2019
Q3 | – | Sell |
-9,568
| Closed | -$696K | – | 371 |
|
|
2019
Q2 | $696K | Buy |
+9,568
| New | +$696K | 0.41% | 38 |
|
|
2019
Q1 | – | Sell |
-4,335
| Closed | -$400K | – | 363 |
|
|
2018
Q4 | $400K | Buy |
+4,335
| New | +$400K | 0.33% | 110 |
|